Works matching IS 00207136 AND DT 2025 AND VI 156 AND IP 7

Results: 18
    1
    2
    3
    4

    A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure.

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 7, p. 1439, doi. 10.1002/ijc.35295
    By:
    • Yamamoto, Akinaru;
    • Kawashima, Atsunari;
    • Uemura, Toshihiro;
    • Nakano, Kosuke;
    • Matsushita, Makoto;
    • Ishizuya, Yu;
    • Jingushi, Kentaro;
    • Hase, Hiroaki;
    • Katayama, Kotoe;
    • Yamaguchi, Rui;
    • Sassi, Nesrine;
    • Motoyama, Yuichi;
    • Nojima, Satoshi;
    • Mita, Masashi;
    • Kimura, Tomonori;
    • Motooka, Daisuke;
    • Horibe, Yuki;
    • Okuda, Yohei;
    • Oka, Toshiki;
    • Yamamichi, Gaku
    Publication type:
    Article
    5

    Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial.

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 7, p. 1326, doi. 10.1002/ijc.35288
    By:
    • Grünwald, Viktor;
    • McKay, Rana R.;
    • Buchler, Tomas;
    • Eto, Masatoshi;
    • Park, Se Hoon;
    • Takagi, Toshio;
    • Zanetta, Sylvie;
    • Keizman, Daniel;
    • Suárez, Cristina;
    • Négrier, Sylvie;
    • Lee, Jae Lyun;
    • Santini, Daniele;
    • Bedke, Jens;
    • Staehler, Michael;
    • Kollmannsberger, Christian;
    • Choueiri, Toni K.;
    • Motzer, Robert J.;
    • Burgents, Joseph E.;
    • Xie, Ran;
    • Okpara, Chinyere E.
    Publication type:
    Article
    6
    7
    8
    9
    10

    Prognostic impact of PD‐L1 expression in surgically resected EGFR‐mutant lung adenocarcinoma: A real‐world database study in Japan (CReGYT‐01 EGFR study).

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 7, p. 1480, doi. 10.1002/ijc.35270
    By:
    • Nomura, Kotaro;
    • Takada, Kazuki;
    • Kinoshita, Fumihiko;
    • Muto, Satoshi;
    • Matsubara, Taichi;
    • Kouki, Yasunobu;
    • Katsumata, Shinya;
    • Hamada, Akira;
    • Haratake, Naoki;
    • Fujino, Kosuke;
    • Yoshikawa, Mao;
    • Suzawa, Ken;
    • Shien, Kazuhiko;
    • Suda, Kenichi;
    • Ohara, Shuta;
    • Fukuda, Shota;
    • Suzuki, Hiroyuki;
    • Okamoto, Tatsuro;
    • Hirai, Fumihiko;
    • Aokage, Keiju
    Publication type:
    Article
    11

    Tislelizumab combined with nab‐paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two‐cohort, phase 2 trial.

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 7, p. 1429, doi. 10.1002/ijc.35261
    By:
    • Wang, Jie;
    • Li, Bin;
    • Zhang, Yawei;
    • Luo, Xiaoyang;
    • Zhang, Yiliang;
    • Li, Hang;
    • Pan, Yunjian;
    • Shao, Longlong;
    • Zheng, Shanbo;
    • Yuan, Chongze;
    • Li, Yuan;
    • Zheng, Qiang;
    • Sun, Si;
    • Zhao, Weixin;
    • Sun, Yihua
    Publication type:
    Article
    12
    13
    14

    Non‐steroidal anti‐inflammatory drug use and inflammatory markers associated with gallbladder dysplasia: A case–control analysis within a series of patients undergoing cholecystectomy.

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 7, p. 1380, doi. 10.1002/ijc.35238
    By:
    • Rosa, Lorena;
    • Cook, Paz;
    • Pfeiffer, Ruth M.;
    • Kemp, Troy J.;
    • Hildesheim, Allan;
    • Pehlivanoglu, Burcin;
    • Adsay, Volkan;
    • Bellolio, Enrique;
    • Araya, Juan Carlos;
    • Pinto, Ligia;
    • Ferreccio, Catterina;
    • Aguayo, Gloria;
    • Viñuela, Eduardo;
    • Koshiol, Jill
    Publication type:
    Article
    15
    16
    17
    18

    Issue Information.

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 7, p. 1307, doi. 10.1002/ijc.35013
    Publication type:
    Article